USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
20 Oct 2021 | 02:45 PM GMT
Past Meeting

Companion DTx: clinical & economic evidence

Anchored by:

Jin Lee
Director of Digital Health
ASTELLAS PHARMA, INC
Jordan Silberman
Dir of Clinical Analytics & Research
ELEVANCE HEALTH

Participants:

Jin Lee Director of Digital HealthAstellas Pharma, IncOther
Other
Jin Lee
Director of Digital HealthAstellas Pharma, Inc
Jordan Silberman Dir of Clinical Analytics & ResearchElevance HealthOther
Other
Jordan Silberman
Dir of Clinical Analytics & ResearchElevance Health
Chandana Fitzgerald President, CommunityHLTHOther
Other
Chandana Fitzgerald
President, CommunityHLTH
Aahuti Rai Health Innovation Leader & Venture PartnerFour Points HealthHealth Tech & Solutions
Health Tech & Solutions
Aahuti Rai
Health Innovation Leader & Venture PartnerFour Points Health
Arthur Bretonnet Global Digital Innovation LeadUCB Pharma
Arthur Bretonnet
Global Digital Innovation LeadUCB Pharma
Bernhard Kappe Founder & CEOOrthogonal
Bernhard Kappe
Founder & CEOOrthogonal
Celine Ulmann Project ManagementNovartis Institutes for BioMedical Research (NIBR)
Celine Ulmann
Project ManagementNovartis Institutes for BioMedical Research (NIBR)
Gregoire Guillet CBO - Digital FactoryServierLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Gregoire Guillet
CBO - Digital FactoryServier
John Gordon Commercial Lead, International MarketsPfizerOther
Other
John Gordon
Commercial Lead, International MarketsPfizer
Joseph Rubinsztain CEOChronWell
Joseph Rubinsztain
CEOChronWell
Krys Zaluski Director, External GrowthBiogenLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Krys Zaluski
Director, External GrowthBiogen
Laura Lang Medical Science ManagerKaiku Health
Laura Lang
Medical Science ManagerKaiku Health
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected HealthProfessional Services
Professional Services
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Reginald Swift Founder & CEORubix LSLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Reginald Swift
Founder & CEORubix LS

About this Meeting

Commercialization of DTx solutions as digital drug companions seems to be a valuable route to market for DTx companies and a good option for pharma companies, which are still wary of incorporating standalone DTx in their portfolios. However, there are still a lot of questions around the evidence generation for companion DTx. Join us in this informal conversation where we will talk about:   
  •  Level of clinical and economic evidence required - how does this change depending on the stakeholder, mode of action, risk of the product, etc?
  •  Companion DTx and drugs are currently regulated separately; but when it comes to clinical evidence, should DTx - drug be validated together? What are the barriers and challenges to do this? 
  •  Particularities of the study design for companion DTx.  
  •  Role of the DTx company vs. role of pharma in evidence generation  
  •  What is the most efficient way to generate economic evidence?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.

© 2026 HLTH, INC. by Hyve Group - All Rights Reserved

About usPrivacy Policy Contact us